Published in J Clin Endocrinol Metab on May 01, 2004
Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol (2013) 2.47
Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern Med (2013) 2.05
Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care (2011) 1.91
The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag (2009) 1.90
A practical guide to male hypogonadism in the primary care setting. Int J Clin Pract (2010) 1.90
Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol (2007) 1.79
Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels. J Clin Endocrinol Metab (2009) 1.78
Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endocrinol Metab (2006) 1.63
Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013. JAMA (2017) 1.41
Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. Nat Rev Endocrinol (2015) 1.39
Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy. Ann Pharmacother (2014) 1.25
Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy. Int J Endocrinol (2012) 1.18
Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol (2011) 1.03
Patient satisfaction with testosterone replacement therapies: the reasons behind the choices. J Sex Med (2013) 1.02
Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr Rev (2012) 1.01
Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Osteoporos Int (2010) 0.99
Testosterone for the aging male; current evidence and recommended practice. Clin Interv Aging (2008) 0.98
The effect of food composition on serum testosterone levels after oral administration of Andriol Testocaps. Clin Endocrinol (Oxf) (2007) 0.98
Selective androgen receptor modulators as function promoting therapies. Curr Opin Clin Nutr Metab Care (2009) 0.98
Reexamination of pharmacokinetics of oral testosterone undecanoate in hypogonadal men with a new self-emulsifying formulation. J Androl (2011) 0.96
A new combination of testosterone and nestorone transdermal gels for male hormonal contraception. J Clin Endocrinol Metab (2012) 0.93
Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men. J Clin Endocrinol Metab (2009) 0.93
The dominance behavioral system and psychopathology: evidence from self-report, observational, and biological studies. Psychol Bull (2012) 0.93
Testosterone increases the muscle protein synthesis rate but does not affect very-low-density lipoprotein metabolism in obese premenopausal women. Am J Physiol Endocrinol Metab (2012) 0.92
Testosterone deficiency and cardiovascular mortality. Asian J Androl (2015) 0.90
Biochemical assessment of bone turnover and bone fragility in men. Osteoporos Int (2007) 0.90
Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation. J Cell Biochem (2011) 0.89
Prevalence and psychosocial correlates of depressive symptoms among adolescents and adults with Klinefelter syndrome. Genet Med (2011) 0.87
Safety and efficacy of testosterone gel in the treatment of male hypogonadism. Clin Interv Aging (2009) 0.87
Sex steroids and bone health status in men. Int J Endocrinol (2012) 0.87
Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes. Diabetes Care (2015) 0.87
Prevalence of pituitary hormone dysfunction, metabolic syndrome, and impaired quality of life in retired professional football players: a prospective study. J Neurotrauma (2014) 0.86
Testosterone Therapy in Men With Prostate Cancer. Eur Urol (2015) 0.85
A practical guide to diagnosis, management and treatment of testosterone deficiency for Canadian physicians. Can Urol Assoc J (2010) 0.85
Testosterone and progesterone, but not estradiol, stimulate muscle protein synthesis in postmenopausal women. J Clin Endocrinol Metab (2013) 0.85
Hypogonadism in male cancer patients. J Cachexia Sarcopenia Muscle (2012) 0.85
Signaling pathways implicated in androgen regulation of endocortical bone. Bone (2009) 0.84
Testosterone replacement and bone mineral density in male pituitary tumor patients. Endocrinol Metab (Seoul) (2014) 0.84
Selective androgen receptor modulators for the treatment of late onset male hypogonadism. Asian J Androl (2014) 0.83
Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients. Reprod Biol Endocrinol (2011) 0.83
Bone vs. fat: embryonic origin of progenitors determines response to androgen in adipocytes and osteoblasts. Bone (2011) 0.83
The role of estrogen in the treatment of men with schizophrenia. Int J Endocrinol Metab (2013) 0.83
The effect of testosterone replacement therapy on prostate-specific antigen (PSA) levels in men being treated for hypogonadism: a systematic review and meta-analysis. Medicine (Baltimore) (2015) 0.83
Radionuclide decorporation: matching the biokinetics of actinides by transdermal delivery of pro-chelators. AAPS J (2013) 0.82
The many faces of testosterone. Clin Interv Aging (2007) 0.82
Management of osteoporosis in the aging male: focus on zoledronic acid. Clin Interv Aging (2009) 0.82
Testosterone depot injection in male hypogonadism: a critical appraisal. Clin Interv Aging (2007) 0.82
Acute gonadotroph and somatotroph hormonal suppression after traumatic brain injury. J Neurotrauma (2010) 0.82
Percentage extremity fat, but not percentage trunk fat, is lower in adolescent boys with anorexia nervosa than in healthy adolescents. Am J Clin Nutr (2008) 0.81
Male hormonal contraception. Virtual Mentor (2012) 0.81
Combined choroidal neovascularization and hypopituitarism in a patient with homozygous mutation in methylenetetrahydrofolate reductase gene. J Res Med Sci (2014) 0.80
The effect of testosterone on mood and well-being in men with erectile dysfunction in a randomized, placebo-controlled trial. Andrology (2013) 0.80
An update on male hypogonadism therapy. Expert Opin Pharmacother (2014) 0.80
A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel. Aging Male (2013) 0.79
Ovarian Features after 2 Weeks, 3 Weeks and 4 Weeks Transdermal Testosterone Gel Treatment and Their Associated Effect on IVF Outcomes in Poor Responders. Balsaenggwa Saengsig (2014) 0.79
Osteopenia and male hypogonadism. Rev Urol (2004) 0.79
Androgens and the cerebrovasculature: modulation of vascular function during normal and pathophysiological conditions. Pflugers Arch (2013) 0.78
Environmental exposure to di-2-ethylhexyl phthalate is associated with low interest in sexual activity in premenopausal women. Horm Behav (2014) 0.78
Voice and handgrip strength predict reproductive success in a group of indigenous African females. PLoS One (2012) 0.78
Androgen prevents hypogonadal bone loss via inhibition of resorption mediated by mature osteoblasts/osteocytes. Bone (2012) 0.78
Influence of testosterone replacement therapy on metabolic disorders in male patients with type 2 diabetes mellitus and androgen deficiency. Eur J Med Res (2014) 0.78
Stem cell activation in adults can reverse detrimental changes in body composition to reduce fat and increase lean mass in both sexes. J Cell Biochem (2011) 0.77
Androgens and male aging: Current evidence of safety and efficacy. Asian J Androl (2010) 0.77
Evolution of testosterone treatment over 25 years: symptom responses, endocrine profiles and cardiovascular changes. Aging Male (2015) 0.77
Testosterone Replacement Therapy and Prostate Cancer Incidence. World J Mens Health (2015) 0.77
Testis Development and Fertility Potential in Boys with Klinefelter Syndrome. Endocrinol Metab Clin North Am (2015) 0.77
Detection of Growth Hormone Deficiency in Adults with Chronic Traumatic Brain Injury. J Neurotrauma (2015) 0.76
Male hormonal contraception: looking back and moving forward. Andrology (2015) 0.76
Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy. Transl Androl Urol (2016) 0.75
The Role of Estrogen Modulators in Male Hypogonadism and Infertility. Rev Urol (2016) 0.75
Serum testosterone level, testosterone replacement treatment, and prostate cancer. Adv Urol (2013) 0.75
Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return? Investig Clin Urol (2016) 0.75
Stable Intraprostatic Dihydrotestosterone in Healthy Medically Castrate Men Treated With Exogenous Testosterone. J Clin Endocrinol Metab (2016) 0.75
Crystallization and preliminary X-ray analysis of the human androgen receptor ligand-binding domain with a coactivator-like peptide and selective androgen receptor modulators. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.75
Pharmacokinetics and drying time of testosterone 2% gel in men with hypogonadism: a multicenter, open-label, single-arm trial. Int J Impot Res (2014) 0.75
Predicting low testosterone in aging men: a systematic review. CMAJ (2016) 0.75
Beyond the Condom: Frontiers in Male Contraception. Semin Reprod Med (2016) 0.75
A critical analysis of testosterone supplementation therapy and cardiovascular risk in elderly men. Can Urol Assoc J (2014) 0.75
Battle of the sex steroids in the male skeleton: and the winner is…. J Clin Invest (2016) 0.75
Testosterone deficiency in adults and corresponding treatment patterns across the globe. Transl Androl Urol (2017) 0.75
A Case of Male Osteoporosis: A 37-Year-Old Man with Multiple Vertebral Compression Fractures. Case Rep Endocrinol (2017) 0.75
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 21.80
Central challenges facing the national clinical research enterprise. JAMA (2003) 17.41
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 7.15
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. Cancer Res (2007) 5.97
Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2006) 5.58
Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimers Dement (2010) 4.85
Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants. Clin Cancer Res (2011) 4.65
Impact of HIV infection and HAART on serum lipids in men. JAMA (2003) 4.01
Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat Genet (2003) 3.78
Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens (2012) 3.73
Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab (2004) 3.45
Reconstitution of Ca2+-regulated membrane fusion by synaptotagmin and SNAREs. Science (2004) 3.24
Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab (2004) 3.02
Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors. Cancer Res (2011) 2.81
Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab (2004) 2.73
Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects. J Clin Endocrinol Metab (2003) 2.59
Persistent intraprostatic androgen concentrations after medical castration in healthy men. J Clin Endocrinol Metab (2006) 2.57
Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab (2004) 2.39
Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans. J Clin Endocrinol Metab (2007) 2.36
Immediate and delayed effects of cognitive interventions in healthy elderly: a review of current literature and future directions. Alzheimers Dement (2009) 2.30
Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab (2012) 2.29
Low serum testosterone and mortality in male veterans. Arch Intern Med (2006) 2.28
Regulation of membrane fusion by the membrane-proximal coil of the t-SNARE during zippering of SNAREpins. J Cell Biol (2002) 2.13
Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care (2007) 2.08
Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association. Hypertension (2015) 2.01
Cilia-driven leftward flow determines laterality in Xenopus. Curr Biol (2007) 1.97
An analysis of dialysis training in the United States and Canada. Am J Kidney Dis (2002) 1.78
American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update. Endocr Pract (2004) 1.69
Effect of testosterone replacement on trabecular architecture in hypogonadal men. J Bone Miner Res (2005) 1.67
Creating a new structure for research on health care effectiveness. J Investig Med (2005) 1.64
Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care (2011) 1.60
Pituitary hormonal loss and recovery after transsphenoidal adenoma removal. Neurosurgery (2008) 1.58
Bicaudal C, a novel regulator of Dvl signaling abutting RNA-processing bodies, controls cilia orientation and leftward flow. Development (2009) 1.58
The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann Surg (2011) 1.55
The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men. J Clin Endocrinol Metab (2007) 1.53
Prevalence of complementary and alternative medicine use among HIV patients for perceived lipodystrophy. J Altern Complement Med (2006) 1.51
Pituitary function after endonasal surgery for nonadenomatous parasellar tumors: Rathke's cleft cysts, craniopharyngiomas, and meningiomas. Surg Neurol (2008) 1.50
Structural basis for the cyclization of the lipopeptide antibiotic surfactin by the thioesterase domain SrfTE. Structure (2002) 1.49
Liposome fusion assay to monitor intracellular membrane fusion machines. Methods Enzymol (2003) 1.49
Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care (2004) 1.47
On a dark-field signal generated by micrometer-sized calcifications in phase-contrast mammography. Phys Med Biol (2013) 1.47
Gene therapy for heart failure. Circ Res (2012) 1.46
The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials (2014) 1.46
Intratesticular androgens and spermatogenesis during severe gonadotropin suppression induced by male hormonal contraceptive treatment. J Androl (2007) 1.45
In vivo magnetic resonance detects rapid remodeling changes in the topology of the trabecular bone network after menopause and the protective effect of estradiol. J Bone Miner Res (2008) 1.45
Outcomes and costs of acute treatment of traumatic brain injury. J Trauma (2002) 1.44
Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial. Fertil Steril (2012) 1.44
Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men. Cancer Causes Control (2009) 1.43
Low-fat high-fiber diet decreased serum and urine androgens in men. J Clin Endocrinol Metab (2005) 1.42
Relationship between reduced elasticity of extracardiac vessels and left main stem coronary artery disease. Eur Heart J (2004) 1.40
Cyclosporine area under the curve after allogeneic hematopoietic stem cell transplantation is an indicator of Epstein-Barr virus DNAemia. Leuk Lymphoma (2012) 1.40
Development of an advanced hyperspectral imaging (HSI) system with applications for cancer detection. Ann Biomed Eng (2006) 1.40
Serum testosterone and estradiol in sudden infant death. J Pediatr (2005) 1.40
In vivo microMRI-based finite element and morphological analyses of tibial trabecular bone in eugonadal and hypogonadal men before and after testosterone treatment. J Bone Miner Res (2008) 1.40
Testosterone administration decreases generosity in the ultimatum game. PLoS One (2009) 1.40
Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology (2004) 1.38
Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev (2006) 1.37
The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J Clin Endocrinol Metab (2008) 1.37
Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J Dev Behav Pediatr (2003) 1.36
Deterioration of trabecular architecture in hypogonadal men. J Clin Endocrinol Metab (2003) 1.36
Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models. Mol Ther (2011) 1.34
Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry (2004) 1.30
Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men. Clin Endocrinol (Oxf) (2007) 1.30
Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet (2006) 1.30
Improvement of nutritional status after initiation of maintenance hemodialysis. Am J Kidney Dis (2002) 1.30
The promotion of oriented axonal regrowth in the injured spinal cord by alginate-based anisotropic capillary hydrogels. Biomaterials (2006) 1.30
Translating clinical research into practice: practice-based research networks--a promising solution. J Investig Med (2003) 1.30
Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab (2010) 1.29
Increased salivary cortisol concentrations during chronic alcohol intoxication in a naturalistic clinical sample of men. Alcohol Clin Exp Res (2003) 1.27
Anthropometrics and examiner-reported body habitus abnormalities in the multicenter AIDS cohort study. Clin Infect Dis (2004) 1.27
Flow on the right side of the gastrocoel roof plate is dispensable for symmetry breakage in the frog Xenopus laevis. Dev Biol (2009) 1.26
Epidermal wound repair is regulated by the planar cell polarity signaling pathway. Dev Cell (2010) 1.25
Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study. Am J Epidemiol (2004) 1.25
Drug-induced gynecomastia. Expert Opin Drug Saf (2008) 1.24
Trabecular structure quantified with the MRI-based virtual bone biopsy in postmenopausal women contributes to vertebral deformity burden independent of areal vertebral BMD. J Bone Miner Res (2008) 1.24
Illicit drug use and HIV treatment outcomes in a US cohort. AIDS (2008) 1.24
Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy. Hepatology (2005) 1.24
Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc (2003) 1.24
Testosterone administration suppresses adiponectin levels in men. J Androl (2004) 1.24
Role of magnetic resonance for assessing structure and function of trabecular bone. Top Magn Reson Imaging (2002) 1.23
The nodal inhibitor Coco is a critical target of leftward flow in Xenopus. Curr Biol (2010) 1.23
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort. Mult Scler (2013) 1.22
Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia. J Urol (2004) 1.22